Thrombotic microangiopathy in a sirolimustreated renal transplant patient receiving gemcitabine for lung cancer

Clinical Nephrology

Volumn 67, Issue 2, 2007, Pages 114-118

  Courtellemont, C ^a   Guitard, J ^a   Mehrenberger, M ^a   Pontier, S ^a   Ribes, D ^a   Kamar, N ^a   Esposito, L ^a   Modesto, A ^a   Rostaing, L ^a  

^a CHU RANGUEIL   (France)

Author keywords

Fresh frozen plasma; Gemcitabine; Kidney transplantation; Non small cell lung carcinoma; Sirolimus; Thrombotic microangiopathy

Indexed keywords

C REACTIVE PROTEIN; CARBOPLATIN; CREATININE; CYCLOSPORIN A; FRESH FROZEN PLASMA; GEMCITABINE; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; UREA; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DEATH; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ERYTHROCYTE; GRAFT RECIPIENT; GRAFT REJECTION; HEMATURIA; HEMODIALYSIS; HEMOLYSIS; HEMOLYTIC ANEMIA; HOSPITAL ADMISSION; HUMAN; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; PERIPHERAL EDEMA; PERITONEUM METASTASIS; PROTEINURIA; RETICULOCYTE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREA NITROGEN BLOOD LEVEL; WEAKNESS; CHEMICALLY INDUCED DISORDER; IMMUNE DEFICIENCY; IMMUNOLOGY; LUNG TUMOR; MIDDLE AGED;

ANEMIA, HEMOLYTIC; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; SIROLIMUS; THROMBOCYTOPENIA;

EID: 33847335995     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP67114     Document Type: Article

References (14)

1. Brodowicz T, Breiteneder S, Wiltschke C, Zielinski CC. Gemcitabine-induced hemolytic uremic syndrome: a case report. J Natl Cancer Inst. 1997; 89: 1895-1896.
2. Fung MC, Storniolo AM, Nguyen B et al. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer. 1999; 85: 2023-2032.
3. Gordon LI, Kwaan HC. Cancer and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol. 1997; 34: 140-147.
4. Humreys BD, Sharman JP, Henderson JM et al. Gemcitabine-associated thrombotic microangiopathy. Cancer. 2004; 100: 2664-2670.
5. Jeske HC, Oberladstätter J, Schneeberger S et al. Gemcitabine with ciclosporine or with tacrolimus exerts synergistic effect and induces tolerance in the rat. Transplantation. 2003; 76: 1046-1052.
6. Margreiter R, Fischer M, Roberts K et al. Gemcitabine - a novel immunosuppressive agent - prevents rejection in a rat cardiac transplantation model. Transplantation. 1999; 68: 1051-1053.
7. Martoni A, Marino A, Sperandi F et al. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer. 2005; 41: 81-92.
8. Müller S, Schütt P, Bojko P et al. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol. 2005; 84: 110-114.
9. Norris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005; 16: 1035-1050.
10. Pisoni R, Ruggenenti P, Remuzzi G. Drug-induced thrombotic microangiopathy. Drug Saf. 2001; 24:491-501.
11. Rabinowits G, Herchenhom D, Rabinowits G et al. Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic uremic syndrome due to gemcitabine. Anticancer Drugs. 2003; 14: 665-668.
12. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thromboric thrombocytopenic purpura. Kidney Int. 2001; 60: 831-846.
13. Sartelet H, Toupance O, Lorenzato M et al. Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transplant. 2005; 10: 2441-2447.
14. Symmers WS. Thrombotic nucroangiopathy (thrombotic thrombocytopenic purpura) associated with acute hemorrhagic leucoencephalitis and sensitivity to oxophenarsine. Brain. 1956; 79: 511-521.